What is Origent Data Sciences?
Origent Data Sciences is at the forefront of optimizing drug development and clinical trials through sophisticated AI technologies. The company offers predictive models for patient recruitment, clinical decision support tools for early diagnosis of neurodegenerative diseases, and an AI companion app that converts patient narratives into actionable health data. By empowering clinicians and patients with enhanced insights, Origent aims to improve care, accelerate outcomes, and reduce the risks and costs associated with clinical trials, thereby expanding access to novel treatments.
How much funding has Origent Data Sciences raised?
Origent Data Sciences has raised a total of $128K across 1 funding round:
Debt
$128K
Debt (2021): $128K with participation from PPP
What's next for Origent Data Sciences?
With a substantial late-stage funding context, Origent Data Sciences is poised for significant scaling and market penetration. The recent strategic investment is likely to fuel further development of its AI platforms, expand its reach within the pharmaceutical sector, and enhance its capabilities in addressing complex challenges in neurodegenerative disease research. This capital infusion signals strong investor confidence in Origent's ability to revolutionize clinical trial efficiency and patient care through data-driven innovation.
See full Origent Data Sciences company page
